BioPharmaceutical Technology Center Institute: Leading scientists to highlight annual stem cell research symposium

CONTACT: Karin Borgh, (608) 277-2508, karin.borgh@btci.org

MADISON – A cadre of North America’s leading stem cell scientists will be in Madison April 15 for the Fourth Annual Wisconsin Stem Cell Symposium: Cancer, Stem Cells and Cancer Stem Cells.

The public symposium, coordinated by the University of Wisconsin Stem Cell and Regenerative Medicine Center and the BioPharmaceutical Technology Center Institute, brings together world leaders in the area of cancer stem cells, and recruitment of tumor precursor cells.

Featured speakers include Caroline M. Alexander and John S. Kuo of UW-Madison; George Q. Daley and Carla Bender Kim of Harvard Medical School; Peter Dirks of The Hospital for Sick Children, University of Toronto; Luis F. Parada of the University of Texas Southwestern at Dallas; and Max S. Wicha of the University of Michigan.

The symposium’s emphasis this year will be on basic cellular and molecular mechanisms that govern the cell growth potential of tumors, and whether there is a relationship between the long-lived/immortal cells of tumors and the long-lived/immortal cells of somatic tissues.

The daylong symposium, which is open to the public with a registration fee of $90, will be held at Promega Corporation’s BioPharmaceutical Technology Center, 5445 E. Cheryl Parkway, Fitchburg, WI. For more information go to http://www.btci.org